BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2164741)

  • 1. Malignant hyperthermia: relation to other diseases.
    Mortier W
    Acta Anaesthesiol Belg; 1990; 41(2):119-26. PubMed ID: 2164741
    [No Abstract]   [Full Text] [Related]  

  • 2. Standardization of the caffeine halothane muscle contracture test. North American Malignant Hyperthermia Group.
    Larach MG
    Anesth Analg; 1989 Oct; 69(4):511-5. PubMed ID: 2675676
    [No Abstract]   [Full Text] [Related]  

  • 3. Current diagnostic methods of malignant hyperthermia: an evaluation.
    Ording H
    Acta Anaesthesiol Belg; 1990; 41(2):103-6. PubMed ID: 2371801
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuroleptic malignant syndrome and malignant hyperthermia. In vitro comparison with halothane and caffeine contracture tests.
    Krivosic-Horber R; Adnet P; Guevart E; Theunynck D; Lestavel P
    Br J Anaesth; 1987 Dec; 59(12):1554-6. PubMed ID: 3426910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standards for halothane/caffeine contracture test.
    Rosenberg H
    Anesth Analg; 1989 Oct; 69(4):429-30. PubMed ID: 2782641
    [No Abstract]   [Full Text] [Related]  

  • 6. Halothane-caffeine contracture testing in neuromuscular diseases.
    Heiman-Patterson TD; Rosenberg H; Fletcher JE; Tahmoush AJ
    Muscle Nerve; 1988 May; 11(5):453-7. PubMed ID: 3374516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity and new malignant hyperthermia diagnostic procedures.
    Gerbershagen MU; Wappler F
    Acta Anaesthesiol Scand; 2006 Jan; 50(1):127; author reply 127-8. PubMed ID: 16451169
    [No Abstract]   [Full Text] [Related]  

  • 8. Malignant hyperthermia in humans--standardization of contracture testing protocol.
    Melton AT; Martucci RW; Kien ND; Gronert GA
    Anesth Analg; 1989 Oct; 69(4):437-43. PubMed ID: 2782643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fulminant malignant hyperthermia.
    Bross T; Steinmann D
    Acta Anaesthesiol Scand; 2008 Jan; 52(1):164-5. PubMed ID: 18173438
    [No Abstract]   [Full Text] [Related]  

  • 10. Malignant hyperthermia.
    Sessler DI
    Acta Anaesthesiol Scand Suppl; 1996; 109():25-30. PubMed ID: 8901933
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative analysis of in vitro contracture tests with ryanodine and a combination of ryanodine with either halothane or caffeine: a comparative investigation in malignant hyperthermia.
    Bendahan D; Guis S; Monnier N; Kozak-Ribbens G; Lunardi J; Ghattas B; Mattei JP; Cozzone PJ
    Acta Anaesthesiol Scand; 2004 Sep; 48(8):1019-27. PubMed ID: 15315621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic malignant syndrome and malignant hyperthermia.
    Merry SN; Merry AF
    N Z Med J; 1988 Jun; 101(848):431. PubMed ID: 3393339
    [No Abstract]   [Full Text] [Related]  

  • 13. Is neuroleptic malignant syndrome a neurogenic form of malignant hyperthermia?
    Gurrera RJ
    Clin Neuropharmacol; 2002; 25(4):183-93. PubMed ID: 12151905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of the platelet-halothane nucleotide depletion test as a diagnostic or screening test for malignant hyperthermia.
    Britt BA; Scott EA
    Anesth Analg; 1986 Feb; 65(2):171-5. PubMed ID: 3942305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Israeli Diagnostic Center for Malignant Hyperthermia: 7-years' accumulated experience.
    Glauber V; Ben Abraham R; Zweig A; Perel A
    Isr J Med Sci; 1997 Oct; 33(10):643-7. PubMed ID: 9397136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Malignant hyperthermia or neuroleptic malignant syndrome?].
    Quevedo-Arechederra MA; Fraile JR; Rodríguez FM; Bermejo L
    Rev Esp Anestesiol Reanim; 1995 Oct; 42(8):349. PubMed ID: 8560059
    [No Abstract]   [Full Text] [Related]  

  • 17. A case of neuroleptic malignant syndrome: in vitro muscle comparison with malignant hyperthermia.
    Tollefson G
    J Clin Psychopharmacol; 1982 Aug; 2(4):266-70. PubMed ID: 6126494
    [No Abstract]   [Full Text] [Related]  

  • 18. [Malignant hyperthermia and its differential diagnosis].
    Hüttemann K; Nowe T; Köhrmann M; Anetseder M; Schellinger PD
    Fortschr Neurol Psychiatr; 2009 Apr; 77(4):203-11. PubMed ID: 19347791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Malignant hyperthermia and neuroleptic malignant syndrome: report of 4 clinical cases].
    Samuelian JC; Chabannes JM; Vedy P; Kozak-Reiss G
    Encephale; 1999; 25(3):222-5. PubMed ID: 10434147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant hyperthermia and related neuromuscular diseases: caffeine contracture of the skinned muscle fibers.
    Takagi A; Sunohara N; Ishihara T; Nonaka I; Sugita H
    Muscle Nerve; 1983 Sep; 6(7):510-4. PubMed ID: 6633564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.